158 related articles for article (PubMed ID: 35468973)
1. A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2.
Ilinykh PA; Periasamy S; Huang K; Kuzmina NA; Ramanathan P; Meyer MN; Mire CE; Kuzmin IV; Bharaj P; Endsley JR; Chikina M; Sealfon SC; Widen SG; Endsley MA; Bukreyev A
NPJ Vaccines; 2022 Apr; 7(1):47. PubMed ID: 35468973
[TBL] [Abstract][Full Text] [Related]
2. A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters.
Liu X; Luongo C; Matsuoka Y; Park HS; Santos C; Yang L; Moore IN; Afroz S; Johnson RF; Lafont BAP; Martens C; Best SM; Munster VJ; Hollý J; Yewdell JW; Le Nouën C; Munir S; Buchholz UJ
Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34876520
[TBL] [Abstract][Full Text] [Related]
3. Live-attenuated pediatric parainfluenza vaccine expressing 6P-stabilized SARS-CoV-2 spike protein is protective against SARS-CoV-2 variants in hamsters.
Liu X; Park HS; Matsuoka Y; Santos C; Yang L; Luongo C; Moore IN; Johnson RF; Garza NL; Zhang P; Lusso P; Best SM; Buchholz UJ; Le Nouën C
bioRxiv; 2022 Dec; ():. PubMed ID: 36561185
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Parainfluenza Virus 5 (PIV5)-vectored Intranasal COVID-19 Vaccine as a Single Dose Vaccine and as a Booster against SARS-CoV-2 Variants.
Beavis AC; Li Z; Briggs K; Huertas-Díaz MC; Wrobel ER; Najera M; An D; Orr-Burks N; Murray J; Patil P; Huang J; Mousa J; Hao L; Hsiang TY; Gale M; Harvey SB; Tompkins SM; Hogan RJ; Lafontaine ER; Jin H; He B
bioRxiv; 2022 Jun; ():. PubMed ID: 35702147
[TBL] [Abstract][Full Text] [Related]
5. A single intranasal or intramuscular immunization with chimpanzee adenovirus vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
bioRxiv; 2020 Dec; ():. PubMed ID: 33299991
[TBL] [Abstract][Full Text] [Related]
6. Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease.
Warner BM; Santry LA; Leacy A; Chan M; Pham PH; Vendramelli R; Pei Y; Tailor N; Valcourt E; Leung A; He S; Griffin BD; Audet J; Willman M; Tierney K; Albietz A; Frost KL; Yates JGE; Mould RC; Chan L; Mehrani Y; Knapp JP; Minott JA; Banadyga L; Safronetz D; Wood H; Booth S; Major PP; Bridle BW; Susta L; Kobasa D; Wootton SK
iScience; 2021 Nov; 24(11):103219. PubMed ID: 34632328
[TBL] [Abstract][Full Text] [Related]
7. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.
Bricker TL; Darling TL; Hassan AO; Harastani HH; Soung A; Jiang X; Dai YN; Zhao H; Adams LJ; Holtzman MJ; Bailey AL; Case JB; Fremont DH; Klein R; Diamond MS; Boon ACM
Cell Rep; 2021 Jul; 36(3):109400. PubMed ID: 34245672
[TBL] [Abstract][Full Text] [Related]
8. A single dose of replication-competent VSV-vectored vaccine expressing SARS-CoV-2 S1 protects against virus replication in a hamster model of severe COVID-19.
Malherbe DC; Kurup D; Wirblich C; Ronk AJ; Mire C; Kuzmina N; Shaik N; Periasamy S; Hyde MA; Williams JM; Shi PY; Schnell MJ; Bukreyev A
NPJ Vaccines; 2021 Jul; 6(1):91. PubMed ID: 34294728
[TBL] [Abstract][Full Text] [Related]
9. Non-propagative human parainfluenza virus type 2 nasal vaccine robustly protects the upper and lower airways against SARS-CoV-2.
Ohtsuka J; Imai M; Fukumura M; Maeda M; Eguchi A; Ono R; Maemura T; Ito M; Yamayoshi S; Kataoka Y; Kawaoka Y; Nosaka T
iScience; 2021 Dec; 24(12):103379. PubMed ID: 34805782
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
11. Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques.
Nouën CL; Nelson CE; Liu X; Park HS; Matsuoka Y; Luongo C; Santos C; Yang L; Herbert R; Castens A; Moore IN; Wilder-Kofie T; Moore R; Walker A; Zhang P; Lusso P; Johnson RF; Garza NL; Via LE; Munir S; Barber D; Buchholz UJ
bioRxiv; 2022 May; ():. PubMed ID: 35665011
[TBL] [Abstract][Full Text] [Related]
12. Single-Dose Intranasal Administration of AdCOVID Elicits Systemic and Mucosal Immunity against SARS-CoV-2 and Fully Protects Mice from Lethal Challenge.
King RG; Silva-Sanchez A; Peel JN; Botta D; Dickson AM; Pinto AK; Meza-Perez S; Allie SR; Schultz MD; Liu M; Bradley JE; Qiu S; Yang G; Zhou F; Zumaquero E; Simpler TS; Mousseau B; Killian JT; Dean B; Shang Q; Tipper JL; Risley CA; Harrod KS; Feng T; Lee Y; Shiberu B; Krishnan V; Peguillet I; Zhang J; Green TJ; Randall TD; Suschak JJ; Georges B; Brien JD; Lund FE; Roberts MS
Vaccines (Basel); 2021 Aug; 9(8):. PubMed ID: 34452006
[TBL] [Abstract][Full Text] [Related]
13. Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters.
Jia Q; Bielefeldt-Ohmann H; Maison RM; Hartwig A; Masleša-Galić S; Bowen RA; Horwitz MA
Microbiol Spectr; 2023 Mar; 11(2):e0503522. PubMed ID: 36916971
[TBL] [Abstract][Full Text] [Related]
14. Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants.
van Oosten L; Altenburg JJ; Fougeroux C; Geertsema C; van den End F; Evers WAC; Westphal AH; Lindhoud S; van den Berg W; Swarts DC; Deurhof L; Suhrbier A; Le TT; Torres Morales S; Myeni SK; Kikkert M; Sander AF; de Jongh WA; Dagil R; Nielsen MA; Salanti A; Søgaard M; Keijzer TMP; Weijers D; Eppink MHM; Wijffels RH; van Oers MM; Martens DE; Pijlman GP
mBio; 2021 Oct; 12(5):e0181321. PubMed ID: 34634927
[TBL] [Abstract][Full Text] [Related]
15. Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.
Deschambault Y; Lynch J; Warner B; Tierney K; Huynh D; Vendramelli R; Tailor N; Frost K; Sajesh B; LeBlanc K; Layne C; Lin L; Tamming L; Beniac D; Booth S; Carpenter M; Safronetz D; Li X; Kobasa D; Cao J
J Virol; 2022 May; 96(9):e0038922. PubMed ID: 35412347
[TBL] [Abstract][Full Text] [Related]
16. Intranasal immunization with avian paramyxovirus type 3 expressing SARS-CoV-2 spike protein protects hamsters against SARS-CoV-2.
Park HS; Matsuoka Y; Luongo C; Yang L; Santos C; Liu X; Ahlers LRH; Moore IN; Afroz S; Johnson RF; Lafont BAP; Dorward DW; Fischer ER; Martens C; Samal SK; Munir S; Buchholz UJ; Le Nouën C
NPJ Vaccines; 2022 Jun; 7(1):72. PubMed ID: 35764659
[TBL] [Abstract][Full Text] [Related]
17. Single-Dose, Intranasal Immunization with Recombinant Parainfluenza Virus 5 Expressing Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Spike Protein Protects Mice from Fatal MERS-CoV Infection.
Li K; Li Z; Wohlford-Lenane C; Meyerholz DK; Channappanavar R; An D; Perlman S; McCray PB; He B
mBio; 2020 Apr; 11(2):. PubMed ID: 32265331
[TBL] [Abstract][Full Text] [Related]
18. One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infection.
Liu R; Americo JL; Cotter CA; Earl PL; Erez N; Peng C; Moss B
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33688035
[TBL] [Abstract][Full Text] [Related]
19. Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2.
Jawalagatti V; Kirthika P; Hewawaduge C; Yang MS; Park JY; Oh B; Lee JH
Mol Ther; 2022 May; 30(5):1926-1940. PubMed ID: 35123065
[TBL] [Abstract][Full Text] [Related]
20. Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as vaccine candidate.
Sun W; Leist SR; McCroskery S; Liu Y; Slamanig S; Oliva J; Amanat F; Schäfer A; Dinnon KH; García-Sastre A; Krammer F; Baric RS; Palese P
bioRxiv; 2020 Jul; ():. PubMed ID: 32743571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
